Claris Life too gets UK regulator nod Ahmedabad-based drug maker Claris Lifesciences has received approval from the UK drug regulatory agency to sell milrinone injection and ketorolac trometamol solution for injection in the country. Milrinone ... Hindu Business Line, 3 weeks ago
Claris Lifesciences Q3 PAT up 32% at Rs 20 cr - Business Standard, 1 month ago
Claris Lifesciences (₹176.15): BUY - Hindu Business Line, 1 month ago
1 images for "claris lifesciences"
[November 07, 2014] (Indian Business Insight Via Acquire Media NewsEdge) Claris Lifesciences, sterile injectable manufacturer, has completed the transfer of its speciality injectable business to its subsidiary Claris Injectables.TMC Net, 1 month ago Claris Lifesciences : COMPLETES TRANSFER OF BIZ 4 Traders, 1 month ago Claris Life completes transfer of its speciality injectable biz to Claris Injectables Money Control, 1 month ago Claris completes transfer of speciality injectable business Business Standard, 1 month ago
|Hindu Business Line, 1 month ago Podcast (English): Claris Lifesciences by Lavanya Prabhakaran Hindu Business Line, 1 month ago|
This page uses frames, but your browser doesn'tCapital Market, 1 month ago Claris Lifesciences: Outcome of board meeting Money Control, 1 month ago
I am sure the company can give about 30% return in the next six months to 12 months. Hence, we suggest buying Claris Lifesciences. DON'T MISS any stories, follow us on Twitter Follow Follow this section for latest news on Recos EmailRSS Have something to say? ...Economic Times, 1 month ago
Capital Market November 11, 2014 Last Updated at 08:08 ISTBusiness Standard, 1 month ago Claris Lifesciences standalone net profit declines 42.08% in the September 2014 quarter HDFC Securities, 1 month ago
AHMEDABAD: Ahmedabad based Torrent Pharmaceuticals Ltd's (TPL) market capitalization jumped to $3.028 billion (Rs 18,831.53 crore) on Monday, becoming the second pharma company from Gujarat to cross the $3 billion mark. Cadila Healthcare Ltd was ...Times of India, 2 weeks ago
Despite reduction in prices of several medicines by NPPA, quality problems with US FDA, competition and slowdown in approvals, 50 top Indian pharmaceutical companies registered satisfactory growth in net sales and earnings before depreciation, ...PharmaBiz, 3 weeks ago
Shares of Glenmark Pharmaceuticals will likely remain in demand as the UK Medicines and Healthcare Regulatory Products Agency has allowed the company to sell cromviva capsules, used in the treatment of Gaucher's disease in the UK. Glenmark's arm ...Hindu Business Line, 3 weeks ago
The Organ Preservation Solutions Market to Reach USD 204.9 Million by 2019: Transparency Market Research
Transparency Market Research projects that the global market for organ preservation solutions will grow at a CAGR rate of 16.5% during the forecast period of 2013 to 2019 Albany, NY -- (ReleaseWire) -- 11/13/2014 -- In its latest research report ...Digital Journal, 1 month ago Global Organ Preservation Solutions Market 2014-2018 Stock Nod, 1 month ago Organ Preservation Solutions Market to Grow at 16.85% CAGR to 2018 Forecast a New Research Report at Sandlerresearch.org Red Orbit, 1 month ago
on your WebpageAdd Widget >Get your members hooked!